Chris Evert Announces Ovarian Cancer Recurrence, Steps Back From Public Role
Former tennis champion Chris Evert has revealed her ovarian cancer has returned for the third time, prompting her to step back from public appearances, according to a statement shared by her foundation on May 15, 2024. The 65-year-old, a seven-time Grand Slam winner, first disclosed her diagnosis in 2018, with subsequent treatments including surgery and chemotherapy.
What Is Ovarian Cancer Recurrence?
Ovarian cancer recurrence occurs when cancer cells reappear after initial treatment, often in the same area or elsewhere in the body. According to the American Cancer Society, about 70% of ovarian cancer cases recur within five years, with survival rates dropping significantly after the first relapse. Evert’s third recurrence underscores the challenges of managing this disease, which often requires repeated rounds of therapy.
How Has Evert Managed Her Cancer Journey?
Evert’s public advocacy for cancer awareness began after her initial diagnosis in 2018, when she underwent a hysterectomy and chemotherapy. A 2020 report by *Sports Illustrated* noted she opted for a personalized treatment plan involving targeted therapy. Her foundation, the Chris Evert Foundation, has since raised over $10 million for cancer research and patient support programs.
What Are the Implications of a Third Recurrence?
A third recurrence is considered a significant milestone in ovarian cancer care, as it often indicates resistance to standard treatments. Dr. Karen Lu, a gynecologic oncologist at MD Anderson Cancer Center, explained that patients in this phase may explore clinical trials or experimental therapies. “The goal shifts from cure to managing symptoms and extending quality of life,” Lu said in a 2023 interview with *Cancer Network*.
How Does Evert’s Case Compare to Other Public Figures?
Evert joins a small group of high-profile athletes who have faced recurrent cancers. Tennis legend Arthur Ashe, who died of AIDS in 1993, and golfer Gary Player, who has managed prostate cancer for decades, are often cited as examples of long-term disease management. Unlike Ashe, Evert has not disclosed specific treatment details beyond her foundation’s statements.
What Support Systems Are Available for Patients?
The National Cancer Institute recommends multidisciplinary care, including genetic counseling, for ovarian cancer survivors. Evert’s foundation offers free genetic testing through its “Evert for Women” initiative, which has screened over 15,000 individuals since 2019. Patients are also encouraged to join support groups, such as those facilitated by the Ovarian Cancer Alliance.
What’s Next for Evert?
Evert’s statement emphasized her focus on “personalized care and time with family,” though no specific treatment plans were outlined. Her foundation confirmed she will remain involved in advocacy work, including funding research into early detection methods. “Chris is a resilient leader, and her transparency continues to inspire others,” said a spokesperson for the foundation.